[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Methimazole.]
[G03XB02, ulipristal, The metabolism of Ulipristal can be decreased when combined with Methimazole.]
[B01AD01, streptokinase, Methimazole may increase the anticoagulant activities of Streptokinase.]
[J01GA01, streptomycin, Methimazole may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Methimazole.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Methimazole.]
[L04AA27, fingolimod, Methimazole may increase the immunosuppressive activities of Fingolimod.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01CG01, sulbactam, Methimazole may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The metabolism of Sulfadiazine can be decreased when combined with Methimazole.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Methimazole.]
[M04AB02, sulfinpyrazone, The metabolism of Sulfinpyrazone can be decreased when combined with Methimazole.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[A10BB04, glibornuride, The therapeutic efficacy of Glibornuride can be decreased when used in combination with Methimazole.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BB02, mercaptopurine, Methimazole may decrease the excretion rate of Mercaptopurine which could result in a higher serum level.]
[N06DA01, tacrine, The metabolism of Tacrine can be decreased when combined with Methimazole.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Methimazole.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Methimazole.]
[R03CC03, terbutaline, The risk or severity of adverse effects can be increased when Terbutaline is combined with Methimazole.]
[B01AE07, dabigatran etexilate, Methimazole may increase the anticoagulant activities of Dabigatran etexilate.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Methimazole.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Methimazole.]
[S03AA02, tetracycline, The metabolism of Tetracycline can be decreased when combined with Methimazole.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N05AE05, lurasidone, The metabolism of Lurasidone can be decreased when combined with Methimazole.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Methimazole.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Methimazole.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Methimazole is combined with Thalidomide.]
[R03DA07, theobromine, Methimazole may decrease the excretion rate of Theobromine which could result in a higher serum level.]
[R03DA04, theophylline, The excretion of Theophylline can be decreased when combined with Methimazole.]
[P02CA02, thiabendazole, The metabolism of Thiabendazole can be decreased when combined with Methimazole.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Methimazole is combined with Eribulin.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Methimazole.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Methimazole.]
[N05CA19, thiopental, The metabolism of Thiopental can be decreased when combined with Methimazole.]
[N05AC02, thioridazine, The metabolism of Thioridazine can be decreased when combined with Methimazole.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be decreased when combined with Methimazole.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Methimazole.]
[G04BE06, moxisylyte, Methimazole may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Methimazole may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, The metabolism of Ticlopidine can be decreased when combined with Methimazole.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Methimazole.]
[P01AB02, tinidazole, The metabolism of Tinidazole can be decreased when combined with Methimazole.]
[S01AA12, tobramycin, Methimazole may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, The therapeutic efficacy of Tolazamide can be decreased when used in combination with Methimazole.]
[V04CA01, tolbutamide, The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Methimazole.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Methimazole.]
[C01DX11, trapidil, The risk or severity of bleeding can be increased when Trapidil is combined with Methimazole.]
[N06AX05, trazodone, The serum concentration of Trazodone can be increased when it is combined with Methimazole.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Methimazole.]
[S01BA05, triamcinolone, The metabolism of Triamcinolone can be decreased when combined with Methimazole.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, The metabolism of Triazolam can be decreased when combined with Methimazole.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Methimazole may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, The metabolism of Trifluoperazine can be decreased when combined with Methimazole.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Methimazole.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Methimazole is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Methimazole is combined with Mometasone.]
[A03AA05, trimebutine, The metabolism of Trimebutine can be decreased when combined with Methimazole.]
[S01ED04, metipranolol, The excretion of Metipranolol can be decreased when combined with Methimazole.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Methimazole.]
[J01EA01, trimethoprim, The metabolism of Trimethoprim can be decreased when combined with Methimazole.]
[N06AA06, trimipramine, The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Trimipramine.]
[J01FA08, troleandomycin, The metabolism of Troleandomycin can be decreased when combined with Methimazole.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Methimazole.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Methimazole.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Belimumab.]
[L01FX04, ipilimumab, Methimazole may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Methimazole.]
[R02AA14, oxyquinoline, Methimazole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[L02BX03, abiraterone, The metabolism of Abiraterone can be decreased when combined with Methimazole.]
[A10BH05, linagliptin, The metabolism of Linagliptin can be decreased when combined with Methimazole.]
[J05AP03, boceprevir, The metabolism of Boceprevir can be decreased when combined with Methimazole.]
[J05AP02, telaprevir, The metabolism of Telaprevir can be decreased when combined with Methimazole.]
[J05AG05, rilpivirine, The metabolism of Rilpivirine can be decreased when combined with Methimazole.]
[B01AD04, urokinase, Methimazole may increase the anticoagulant activities of Urokinase.]
[S01AA28, vancomycin, Methimazole may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Methimazole is combined with Belatacept.]
[N03AX21, ezogabine, Methimazole may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Methimazole.]
[R03AC18, indacaterol, The metabolism of Indacaterol can be decreased when combined with Methimazole.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Methimazole.]
[C08DA01, verapamil, The metabolism of Verapamil can be decreased when combined with Methimazole.]
[N06AX09, viloxazine, Methimazole may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Methimazole.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Methimazole.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Methimazole.]
[B03BA01, vitamin B12, The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Methimazole.]
[A11HA03, vitamin E, The metabolism of Vitamin E can be decreased when combined with Methimazole.]
[B01AA03, warfarin, Methimazole may decrease the anticoagulant activities of Warfarin.]
[S01AA13, fusidic acid, The metabolism of Fusidic acid can be decreased when combined with Methimazole.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The metabolism of Zidovudine can be decreased when combined with Methimazole.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Methimazole.]
[J05AE02, indinavir, The metabolism of Indinavir can be decreased when combined with Methimazole.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Methimazole.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Methimazole.]
[M05BA05, tiludronic acid, Methimazole may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Methimazole may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Methimazole.]
[B01AE01, desirudin, Methimazole may increase the anticoagulant activities of Lepirudin.]
[R03DC01, zafirlukast, The metabolism of Zafirlukast can be decreased when combined with Methimazole.]
[A02BC04, rabeprazole, The metabolism of Rabeprazole can be decreased when combined with Methimazole.]
[N05AE04, ziprasidone, The metabolism of Ziprasidone can be decreased when combined with Methimazole.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be decreased when combined with Methimazole.]
[V03AC02, deferiprone, Methimazole may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Methimazole.]
[N02BA01, aspirin, The metabolism of Acetylsalicylic acid can be decreased when combined with Methimazole.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Methimazole.]
[G04BD07, tolterodine, The serum concentration of Tolterodine can be increased when it is combined with Methimazole.]
[J01DH04, doripenem, Methimazole may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, The excretion of Atenolol can be decreased when combined with Methimazole.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Methimazole.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Methimazole.]
[J02AC03, voriconazole, The metabolism of Voriconazole can be decreased when combined with Methimazole.]
[M01CB03, auranofin, Methimazole may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Methimazole.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Methimazole.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Methimazole.]
[H02AB11, prednylidene, The metabolism of Prednylidene can be decreased when combined with Methimazole.]
[B03XA04, peginesatide, Methimazole may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Methimazole is combined with Azacitidine.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Methimazole is combined with Azathioprine.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Methimazole.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[G04BE10, avanafil, The metabolism of Avanafil can be decreased when combined with Methimazole.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Methimazole.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Methimazole.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Methimazole.]
[G04BD12, mirabegron, The metabolism of Mirabegron can be decreased when combined with Methimazole.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Methimazole is combined with Carfilzomib.]
[V03AX03, cobicistat, The metabolism of Cobicistat can be decreased when combined with Methimazole.]
[J05AJ02, elvitegravir, The metabolism of Elvitegravir can be decreased when combined with Methimazole.]
[L02BB04, enzalutamide, The serum concentration of Enzalutamide can be increased when it is combined with Methimazole.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Methimazole.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Methimazole is combined with Teriflunomide.]
[B01AX01, defibrotide, Methimazole may increase the anticoagulant activities of Defibrotide.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Methimazole is combined with Abetimus.]
[H02AA01, aldosterone, The metabolism of Aldosterone can be decreased when combined with Methimazole.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Methimazole.]
[N05CA04, barbital, The metabolism of Barbital can be decreased when combined with Methimazole.]
[C01AA01, acetyldigitoxin, The serum concentration of Acetyldigitoxin can be increased when it is combined with Methimazole.]
[D02BA02, octinoxate, Methimazole may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Nelfinavir can be decreased when combined with Methimazole.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Methimazole is combined with Bendamustine.]
[N04BD02, rasagiline, The metabolism of Rasagiline can be decreased when combined with Methimazole.]
[C08CA13, lercanidipine, The metabolism of Lercanidipine can be decreased when combined with Methimazole.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Methimazole.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Methimazole.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Methimazole.]
[N02CC03, zolmitriptan, The metabolism of Zolmitriptan can be decreased when combined with Methimazole.]
[G04BD10, darifenacin, The metabolism of Darifenacin can be decreased when combined with Methimazole.]
[V09IX04, fluorodeoxyglucose F18, Methimazole may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Methimazole.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Methimazole.]
[V08CA11, gadofosveset, Methimazole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Methimazole.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Methimazole.]
[A16AX08, teduglutide, Methimazole may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Methimazole.]
[J04AK05, bedaquiline, The metabolism of Bedaquiline can be decreased when combined with Methimazole.]
[C04AX11, bencyclane, The metabolism of Bencyclane can be decreased when combined with Methimazole.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Methimazole.]
[A16AX09, glycerol phenylbutyrate, Methimazole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Methimazole.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Methimazole.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[A10BK02, canagliflozin, The metabolism of Canagliflozin can be decreased when combined with Methimazole.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Methimazole is combined with Dimethyl fumarate.]
[A06AX06, tegaserod, The metabolism of Tegaserod can be decreased when combined with Methimazole.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Methimazole.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Methimazole.]
[L03AA12, ancestim, Methimazole may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The metabolism of Celecoxib can be decreased when combined with Methimazole.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Methimazole.]
[N04AC01, benztropine, The metabolism of Benzatropine can be decreased when combined with Methimazole.]
[L01EC02, dabrafenib, The serum concentration of Dabrafenib can be increased when it is combined with Methimazole.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01EE01, trametinib, Methimazole may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Methimazole.]
[V09AX05, florbetapir F-18, Methimazole may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[L01EB03, afatinib, The therapeutic efficacy of Methimazole can be decreased when used in combination with Afatinib.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Methimazole.]
[C08EA02, bepridil, The metabolism of Bepridil can be decreased when combined with Methimazole.]
[C02KX05, riociguat, The serum concentration of Riociguat can be increased when it is combined with Methimazole.]
[L03AA14, lipegfilgrastim, Methimazole may increase the myelosuppressive activities of Lipegfilgrastim.]
[A10BJ03, lixisenatide, Methimazole may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, The metabolism of Macitentan can be decreased when combined with Methimazole.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Methimazole.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Methimazole.]
[G03AC08, etonogestrel, The metabolism of Etonogestrel can be decreased when combined with Methimazole.]
[J05AP05, simeprevir, The metabolism of Simeprevir can be decreased when combined with Methimazole.]
[J05AP08, sofosbuvir, Methimazole may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Methimazole.]
[C01CA27, droxidopa, Methimazole may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[C07AB04, acebutolol, The excretion of Acebutolol can be decreased when combined with Methimazole.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Methimazole.]
[L04AA32, apremilast, The metabolism of Apremilast can be decreased when combined with Methimazole.]
[L02BG02, formestane, Methimazole may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The metabolism of Betamethasone can be decreased when combined with Methimazole.]
[S01ED02, betaxolol, The excretion of Betaxolol can be decreased when combined with Methimazole.]
[B01AE03, argatroban, Methimazole may increase the anticoagulant activities of Argatroban.]
[V03AB34, fomepizole, Methimazole may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C10AB02, bezafibrate, The metabolism of Bezafibrate can be decreased when combined with Methimazole.]
[L04AC11, siltuximab, The risk or severity of adverse effects can be increased when Methimazole is combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Methimazole.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Methimazole.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Vedolizumab.]
[B01AA07, acenocoumarol, Methimazole may decrease the anticoagulant activities of Acenocoumarol.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Methimazole is combined with Belinostat.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Methimazole.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Methimazole.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Methimazole is combined with Peginterferon beta-1a.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Methimazole.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Methimazole.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[A06AH03, naloxegol, The metabolism of Naloxegol can be decreased when combined with Methimazole.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Methimazole is combined with Decitabine.]
[A11HA08, tocophersolan, The metabolism of Tocofersolan can be decreased when combined with Methimazole.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Methimazole is combined with Pirfenidone.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Methimazole.]
[S03AA06, gentamicin, Methimazole may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Methimazole is combined with Blinatumomab.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Methimazole.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Methimazole.]
[B01AA01, dicumarol, Methimazole may decrease the anticoagulant activities of Dicoumarol.]
[B01AF03, edoxaban, Methimazole may increase the anticoagulant activities of Edoxaban.]
[N06AX11, mirtazapine, The metabolism of Mirtazapine can be decreased when combined with Methimazole.]
[L04AC10, secukinumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Methimazole.]
[L01EX08, lenvatinib, The therapeutic efficacy of Methimazole can be decreased when used in combination with Lenvatinib.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Methimazole.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Methimazole.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be decreased when combined with Methimazole.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Methimazole.]
[B01AA11, tioclomarol, Methimazole may decrease the anticoagulant activities of Tioclomarol.]
[C01EB17, ivabradine, The metabolism of Ivabradine can be decreased when combined with Methimazole.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Methimazole.]
[B01AC25, cangrelor, Methimazole may increase the anticoagulant activities of Cangrelor.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Methimazole.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Methimazole.]
[A04AD14, rolapitant, The metabolism of Rolapitant can be decreased when combined with Methimazole.]
[G02CX02, flibanserin, The metabolism of Flibanserin can be decreased when combined with Methimazole.]
[N05AX15, cariprazine, The metabolism of Cariprazine can be decreased when combined with Methimazole.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Methimazole.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be decreased when combined with Methimazole.]
[V03AB37, idarucizumab, Methimazole may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Methimazole.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Mepolizumab.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be decreased when combined with Methimazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Methimazole.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Methimazole.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be increased when it is combined with Methimazole.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Methimazole.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Methimazole.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Methimazole.]
[A10BB31, acetohexamide, The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Methimazole.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Methimazole.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Methimazole.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Methimazole.]
[J05AP11, grazoprevir, The metabolism of Grazoprevir can be decreased when combined with Methimazole.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Methimazole.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Ixekizumab.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Methimazole.]
[N05BA08, bromazepam, The metabolism of Bromazepam can be decreased when combined with Methimazole.]
[N04BC01, bromocriptine, The serum concentration of Bromocriptine can be increased when it is combined with Methimazole.]
[A02AD05, aluminum magnesium silicate, Methimazole may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[R06AB01, brompheniramine, The metabolism of Brompheniramine can be decreased when combined with Methimazole.]
[N06AA19, amineptin, The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Amineptine.]
[C08CA01, amlodipine, The metabolism of Amlodipine can be decreased when combined with Methimazole.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Methimazole.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[S01ED03, levobunolol, The excretion of Levobunolol can be decreased when combined with Methimazole.]
[N01BB01, bupivacaine, The metabolism of Bupivacaine can be decreased when combined with Methimazole.]
[C07AA19, bupranolol, The excretion of Bupranolol can be decreased when combined with Methimazole.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Methimazole.]
[N05BE01, buspirone, The metabolism of Buspirone can be decreased when combined with Methimazole.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Methimazole.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Methimazole is combined with Arsenic trioxide.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Methimazole.]
[M02AA03, clofezone, The metabolism of Rabeprazole can be decreased when combined with Methimazole.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Methimazole.]
[L01XK03, rucaparib, The metabolism of Rucaparib can be decreased when combined with Methimazole.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be decreased when combined with Methimazole.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Brodalumab.]
[L01EF02, ribociclib, The metabolism of Ribociclib can be decreased when combined with Methimazole.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[R03DA08, bamifylline, Methimazole may decrease the excretion rate of Bamifylline which could result in a higher serum level.]
[L04AA36, ocrelizumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Ocrelizumab.]
[A06AH05, naldemedine, Methimazole may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Methimazole.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N06BC01, caffeine, Methimazole may decrease the excretion rate of Caffeine which could result in a higher serum level.]
[D05AX03, calcitriol, The metabolism of Calcitriol can be decreased when combined with Methimazole.]
[P01CA02, benznidazole, Methimazole may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Methimazole.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Linezolid is combined with Methimazole.]
[J05AF06, abacavir, Methimazole may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Tipranavir can be decreased when combined with Methimazole.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Methimazole.]
[L04AB02, infliximab, The risk or severity of adverse effects can be increased when Infliximab is combined with Methimazole.]
[L01EX10, midostaurin, The metabolism of Midostaurin can be decreased when combined with Methimazole.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Methimazole.]
[N04BD03, safinamide, The metabolism of Safinamide can be decreased when combined with Methimazole.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Sarilumab.]
[J01MA23, delafloxacin, Methimazole may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[B01AF04, betrixaban, Methimazole may increase the anticoagulant activities of Betrixaban.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Guselkumab.]
[L01BC06, capecitabine, The metabolism of Capecitabine can be decreased when combined with Methimazole.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Methimazole.]
[L01EH02, neratinib, The serum concentration of Neratinib can be increased when it is combined with Methimazole.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Methimazole is combined with Vorinostat.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Methimazole.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Methimazole.]
[C07AB07, bisoprolol, The excretion of Bisoprolol can be decreased when combined with Methimazole.]
[J05AG03, efavirenz, The metabolism of Efavirenz can be decreased when combined with Methimazole.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C07AA17, bopindolol, The excretion of Bopindolol can be decreased when combined with Methimazole.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Methimazole.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Methimazole.]
[V03AF08, palifermin, The therapeutic efficacy of Palifermin can be decreased when used in combination with Methimazole.]
[N05CD09, brotizolam, The metabolism of Brotizolam can be decreased when combined with Methimazole.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The metabolism of Budesonide can be decreased when combined with Methimazole.]
[C04AX20, buflomedil, The risk or severity of bleeding can be increased when Buflomedil is combined with Methimazole.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Methimazole.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Methimazole.]
[N06AA15, butriptyline, The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Butriptyline.]
[C01AA02, acetyldigoxins, The serum concentration of Acetyldigoxin can be increased when it is combined with Methimazole.]
[N01BX04, capsaicin, The metabolism of Capsaicin can be decreased when combined with Methimazole.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Methimazole may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[V04CD06, macimorelin, The metabolism of Macimorelin can be decreased when combined with Methimazole.]
[L02BB05, apalutamide, The metabolism of Apalutamide can be decreased when combined with Methimazole.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Methimazole.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Methimazole.]
[C07AG02, carvedilol, The excretion of Carvedilol can be decreased when combined with Methimazole.]
[B02BX09, fostamatinib, The metabolism of Fostamatinib can be decreased when combined with Methimazole.]
[N03AX24, cannabidiol, The metabolism of Cannabidiol can be decreased when combined with Methimazole.]
[L04AA37, baricitinib, The metabolism of Baricitinib can be decreased when combined with Methimazole.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Methimazole.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be decreased when combined with Methimazole.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01GB14, plazomicin, Methimazole may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, The excretion of Celiprolol can be decreased when combined with Methimazole.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Methimazole.]
[L01XX62, ivosidenib, The metabolism of Ivosidenib can be decreased when combined with Methimazole.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Methimazole.]
[A16AX14, migalastat, Methimazole may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Methimazole can be decreased when combined with Stiripentol.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Methimazole.]
[J01AA13, eravacycline, The metabolism of Eravacycline can be decreased when combined with Methimazole.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Methimazole.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Methimazole.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[A10BB06, carbutamide, The therapeutic efficacy of Carbutamide can be decreased when used in combination with Methimazole.]
[D08AE05, chloroxylenol, Methimazole may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Methimazole.]
[R03DA02, oxtriphylline, Methimazole may decrease the excretion rate of Oxtriphylline which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[M03BA02, carisoprodol, The metabolism of Carisoprodol can be decreased when combined with Methimazole.]
[R03BB08, revefenacin, The metabolism of Revefenacin can be decreased when combined with Methimazole.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Methimazole.]
[L04AA39, emapalumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Methimazole.]
[L01EX12, larotrectinib, The metabolism of Larotrectinib can be decreased when combined with Methimazole.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Methimazole.]
[L01XJ03, glasdegib, The metabolism of Glasdegib can be decreased when combined with Methimazole.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Ravulizumab.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be decreased when combined with Methimazole.]
[B01AX07, caplacizumab, The risk or severity of bleeding can be increased when Caplacizumab is combined with Methimazole.]
[B01AC23, cilostazol, The serum concentration of Cilostazol can be increased when it is combined with Methimazole.]
[S01ED05, carteolol, The excretion of Carteolol can be decreased when combined with Methimazole.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be decreased when combined with Methimazole.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Methimazole.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Methimazole is combined with Siponimod.]
[J01FA09, clarithromycin, The metabolism of Clarithromycin can be decreased when combined with Methimazole.]
[N06BA14, solriamfetol, Methimazole may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Methimazole.]
[N05BA09, clobazam, The metabolism of Clobazam can be decreased when combined with Methimazole.]
[H02AB14, cloprednol, The metabolism of Cloprednol can be decreased when combined with Methimazole.]
[C09CA06, candesartan, The metabolism of Candesartan can be decreased when combined with Methimazole.]
[L04AB01, etanercept, The risk or severity of adverse effects can be increased when Etanercept is combined with Methimazole.]
[H02AB17, cortivazol, The metabolism of Cortivazol can be decreased when combined with Methimazole.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Risankizumab.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Methimazole.]
[L01FX14, polatuzumab vedotin, The risk or severity of adverse effects can be increased when Methimazole is combined with Polatuzumab vedotin.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01XX66, selinexor, The metabolism of Selinexor can be decreased when combined with Methimazole.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L02BB06, darolutamide, The serum concentration of Darolutamide can be increased when it is combined with Methimazole.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Methimazole.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, The metabolism of Cyclobenzaprine can be decreased when combined with Methimazole.]
[L04AA44, upadacitinib, The metabolism of Upadacitinib can be decreased when combined with Methimazole.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be decreased when combined with Methimazole.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Methimazole.]
[N07XX11, pitolisant, The metabolism of Pitolisant can be decreased when combined with Methimazole.]
[J04AK08, pretomanid, The serum concentration of Pretomanid can be increased when it is combined with Methimazole.]
[J01XX12, lefamulin, The serum concentration of Lefamulin can be increased when it is combined with Methimazole.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Methimazole.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be decreased when combined with Methimazole.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be decreased when used in combination with Methimazole.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be decreased when combined with Methimazole.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[H02AB13, deflazacort, The serum concentration of Deflazacort can be increased when it is combined with Methimazole.]
[G03DB05, demegestone, The metabolism of Demegestone can be decreased when combined with Methimazole.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Methimazole.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Methimazole.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Methimazole is combined with Diroximel fumarate.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Methimazole.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be decreased when combined with Methimazole.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Methimazole.]
[N03AX25, cenobamate, The metabolism of Cenobamate can be decreased when combined with Methimazole.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[M09AX08, golodirsen, Methimazole may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Methimazole.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be increased when it is combined with Methimazole.]
[R06AB02, dexchlorpheniramine, The metabolism of Dexchlorpheniramine can be decreased when combined with Methimazole.]
[S01XA12, dexpanthenol, Methimazole may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[L01EX18, avapritinib, The metabolism of Avapritinib can be decreased when combined with Methimazole.]
[N05CM21, lemborexant, The metabolism of Lemborexant can be decreased when combined with Methimazole.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Methimazole.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Teprotumumab.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be increased when it is combined with Methimazole.]
[N02CD06, rimegepant, The metabolism of Rimegepant can be decreased when combined with Methimazole.]
[J05AB16, remdesivir, The metabolism of Remdesivir can be decreased when combined with Methimazole.]
[H02CA02, osilodrostat, The serum concentration of Osilodrostat can be increased when it is combined with Methimazole.]
[J05AE05, amprenavir, The metabolism of Amprenavir can be decreased when combined with Methimazole.]
[N02CC07, frovatriptan, The metabolism of Frovatriptan can be decreased when combined with Methimazole.]
[L04AA38, ozanimod, The risk or severity of adverse effects can be increased when Methimazole is combined with Ozanimod.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be increased when it is combined with Methimazole.]
[R02AA03, dichlorobenzyl alcohol, Methimazole may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, The metabolism of Dienogest can be decreased when combined with Methimazole.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be decreased when combined with Methimazole.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be decreased when combined with Methimazole.]
[M01AH02, rofecoxib, The metabolism of Rofecoxib can be decreased when combined with Methimazole.]
[L01XF03, bexarotene, The metabolism of Bexarotene can be decreased when combined with Methimazole.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Methimazole.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Methimazole.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Methimazole.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Methimazole.]
[L01EN02, pemigatinib, The metabolism of Pemigatinib can be decreased when combined with Methimazole.]
[L01EH03, tucatinib, The therapeutic efficacy of Methimazole can be decreased when used in combination with Tucatinib.]
[L01EX17, capmatinib, The metabolism of Capmatinib can be decreased when combined with Methimazole.]
[D07XB03, fluprednidene, The metabolism of Fluprednidene can be decreased when combined with Methimazole.]
[P01BE01, artemisinin, The metabolism of Artemisinin can be decreased when combined with Methimazole.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01EX19, ripretinib, The serum concentration of Ripretinib can be increased when it is combined with Methimazole.]
[V08CA05, mangafodipir, Methimazole may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, The metabolism of Selpercatinib can be decreased when combined with Methimazole.]
[B01AE02, lepirudin, Methimazole may increase the anticoagulant activities of Lepirudin.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be decreased when combined with Methimazole.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Methimazole is combined with Inebilizumab.]
[L01XX69, lurbinectedin, The serum concentration of Lurbinectedin can be increased when it is combined with Methimazole.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Methimazole is combined with Stepronin.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Methimazole.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Methimazole.]
[J05AX29, fostemsavir, The metabolism of Fostemsavir can be decreased when combined with Methimazole.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Methimazole.]
[L04AC19, satralizumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be increased when it is combined with Methimazole.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be decreased when combined with Methimazole.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be increased when it is combined with Methimazole.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Methimazole.]
[N05AA01, chlorpromazine, The metabolism of Chlorpromazine can be decreased when combined with Methimazole.]
[A10BB02, chlorpropamide, The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Methimazole.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be decreased when combined with Methimazole.]
[A11CC05, cholecalciferol, The metabolism of Cholecalciferol can be decreased when combined with Methimazole.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N02BA03, choline salicylate, Methimazole may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[N06BX18, vinpocetine, The metabolism of Vinpocetine can be decreased when combined with Methimazole.]
[G03DC06, ethynodiol, The metabolism of Etynodiol can be decreased when combined with Methimazole.]
[M01AB08, etodolac, The metabolism of Etodolac can be decreased when combined with Methimazole.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[A16AX20, lonafarnib, The serum concentration of Lonafarnib can be increased when it is combined with Methimazole.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Methimazole is combined with Fludarabine.]
[L02BX04, relugolix, The metabolism of Relugolix can be decreased when combined with Methimazole.]
[M01AX25, chondroitin sulfates, Methimazole may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L04AD03, voclosporin, The metabolism of Voclosporin can be decreased when combined with Methimazole.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be increased when it is combined with Methimazole.]
[N03AX10, felbamate, The metabolism of Felbamate can be decreased when combined with Methimazole.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N06BA10, fenethylline, Methimazole may decrease the excretion rate of Fenethylline which could result in a higher serum level.]
[C01CA19, fenoldopam, Methimazole may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[N06BA08, fenozolone, The risk or severity of adverse effects can be increased when Fenozolone is combined with Methimazole.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Methimazole.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[R03BA03, flunisolide, The metabolism of Flunisolide can be decreased when combined with Methimazole.]
[S02BA08, fluocinolone acetonide, The metabolism of Fluocinolone acetonide can be decreased when combined with Methimazole.]
[N02BG07, flupirtine, Methimazole may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Methimazole.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be decreased when used in combination with Methimazole.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be decreased when combined with Methimazole.]
[L01EK03, tivozanib, The therapeutic efficacy of Methimazole can be decreased when used in combination with Tivozanib.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Methimazole.]
[A02BA01, cimetidine, Cimetidine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Methimazole.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Methimazole.]
[S03AA07, ciprofloxacin, Ciprofloxacin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Cisplatin is combined with Methimazole.]
[N06AB04, citalopram, Methimazole may increase the QTc-prolonging activities of Citalopram.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Methimazole is combined with Pegcetacoplan.]
[J02AX07, ibrexafungerp, The serum concentration of Ibrexafungerp can be increased when it is combined with Methimazole.]
[C03DA05, finerenone, The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Methimazole.]
[L04AA48, belumosudil, The metabolism of Belumosudil can be decreased when combined with Methimazole.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Methimazole.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Anifrolumab.]
[L01XX74, belzutifan, The serum concentration of Belzutifan can be increased when it is combined with Methimazole.]
[L01EB10, mobocertinib, The serum concentration of Mobocertinib can be increased when it is combined with Methimazole.]
[L01FX23, tisotumab vedotin, The metabolism of Tisotumab vedotin can be decreased when combined with Methimazole.]
[N02CD07, atogepant, The serum concentration of Atogepant can be increased when it is combined with Methimazole.]
[V09AB03, ioflupane I-123, Methimazole may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Methimazole may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Methimazole may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[L04AA59, avacopan, The metabolism of Avacopan can be decreased when combined with Methimazole.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Methimazole.]
[A10BB12, glimepiride, The therapeutic efficacy of Glimepiride can be decreased when used in combination with Methimazole.]
[A10BB08, gliquidone, The therapeutic efficacy of Gliquidone can be decreased when used in combination with Methimazole.]
[R03CC13, clenbuterol, The risk or severity of adverse effects can be increased when Clenbuterol is combined with Methimazole.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Methimazole.]
[N06AX25, St. John's wort extract, The metabolism of St. John's Wort can be decreased when combined with Methimazole.]
[L01EA06, asciminib, The serum concentration of Asciminib can be increased when it is combined with Methimazole.]
[L02BG06, exemestane, The metabolism of Exemestane can be decreased when combined with Methimazole.]
[J05AX10, maribavir, The metabolism of Maribavir can be decreased when combined with Methimazole.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Methimazole is combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Methimazole.]
[B01AD11, tenecteplase, Methimazole may increase the anticoagulant activities of Tenecteplase.]
[C10AB01, clofibrate, The metabolism of Clofibrate can be decreased when combined with Methimazole.]
[B06AX04, mitapivat, The metabolism of Mitapivat can be decreased when combined with Methimazole.]
[N01BB10, levobupivacaine, The metabolism of Levobupivacaine can be decreased when combined with Methimazole.]
[L01EJ03, pacritinib, The serum concentration of Pacritinib can be increased when it is combined with Methimazole.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Methimazole.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be decreased when combined with Methimazole.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Methimazole.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be increased when it is combined with Methimazole.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Methimazole.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Methimazole is combined with Spesolimab.]
[L04AA56, deucravacitinib, The therapeutic efficacy of Methimazole can be decreased when used in combination with Deucravacitinib.]
[N05BA21, clotiazepam, The metabolism of Clotiazepam can be decreased when combined with Methimazole.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Methimazole.]
[A04AA02, granisetron, The metabolism of Granisetron can be decreased when combined with Methimazole.]
[L01XX77, adagrasib, The serum concentration of Adagrasib can be increased when it is combined with Methimazole.]
[N05AH02, clozapine, The risk or severity of neutropenia can be increased when Methimazole is combined with Clozapine.]
[L01EN04, futibatinib, The metabolism of Futibatinib can be decreased when combined with Methimazole.]
[J01GB12, arbekacin, Methimazole may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[M09AX11, palovarotene, The serum concentration of Palovarotene can be increased when it is combined with Methimazole.]
[L04AC21, bimekizumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[R05DA04, codeine, The metabolism of Codeine can be decreased when combined with Methimazole.]
[M04AC01, colchicine, The metabolism of Colchicine can be decreased when combined with Methimazole.]
[J01XB01, colistin, Methimazole may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Methimazole is combined with Leflunomide.]
[A04AA03, tropisetron, Methimazole may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Methimazole.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Methimazole is combined with Nelarabine.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Methimazole.]
[J01FA15, telithromycin, The metabolism of Telithromycin can be decreased when combined with Methimazole.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Methimazole.]
[B01AC10, indobufen, The risk or severity of bleeding can be increased when Indobufen is combined with Methimazole.]
[J05AB14, valganciclovir, Methimazole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Methimazole may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Methimazole may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Methimazole may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Methimazole may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Methimazole may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The metabolism of Valdecoxib can be decreased when combined with Methimazole.]
[C01AA06, lanatoside C, The serum concentration of Lanatoside C can be increased when it is combined with Methimazole.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Methimazole.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Methimazole.]
[J02AC02, itraconazole, The metabolism of Itraconazole can be decreased when combined with Methimazole.]
[B01AB12, bemiparin, Methimazole may increase the anticoagulant activities of Bemiparin.]
[S01AD03, acyclovir, The metabolism of Acyclovir can be decreased when combined with Methimazole.]
[N05BA10, ketazolam, The metabolism of Ketazolam can be decreased when combined with Methimazole.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01EA01, imatinib, The serum concentration of Imatinib can be increased when it is combined with Methimazole.]
[J02AC04, posaconazole, The metabolism of Posaconazole can be decreased when combined with Methimazole.]
[A02BC05, esomeprazole, The metabolism of Esomeprazole can be decreased when combined with Methimazole.]
[C08CA09, lacidipine, The metabolism of Lacidipine can be decreased when combined with Methimazole.]
[N03AX09, lamotrigine, Lamotrigine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[S01BA03, cortisone, The metabolism of Cortisone can be decreased when combined with Methimazole.]
[N07BC04, lofexidine, The metabolism of Lofexidine can be decreased when combined with Methimazole.]
[S01AE04, lomefloxacin, The metabolism of Lomefloxacin can be decreased when combined with Methimazole.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[R06AX13, loratadine, The metabolism of Loratadine can be decreased when combined with Methimazole.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Methimazole may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, The metabolism of Manidipine can be decreased when combined with Methimazole.]
[A08AA09, mefenorex, The risk or severity of adverse effects can be increased when Mefenorex is combined with Methimazole.]
[C07AA14, mepindolol, The excretion of Mepindolol can be decreased when combined with Methimazole.]
[H02AB15, meprednisone, The metabolism of Meprednisone can be decreased when combined with Methimazole.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Methimazole.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C04AX01, cyclandelate, The metabolism of Cyclandelate can be decreased when combined with Methimazole.]
[R03CB02, methoxyphenamine, The risk or severity of adverse effects can be increased when Methoxyphenamine is combined with Methimazole.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be decreased when combined with Methimazole.]
[N05AD03, metylperon, Methimazole may decrease the excretion rate of Melperone which could result in a higher serum level.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Methimazole.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J01FA03, midecamycin, The metabolism of Midecamycin can be decreased when combined with Methimazole.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Methimazole.]
[N06AX07, minaprine, The metabolism of Minaprine can be decreased when combined with Methimazole.]
[S01XA18, cyclosporine, Methimazole may increase the immunosuppressive activities of Cyclosporine.]
[N06AG02, moclobemide, The metabolism of Moclobemide can be decreased when combined with Methimazole.]
[N06BA07, modafinil, The metabolism of Modafinil can be decreased when combined with Methimazole.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Methimazole.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C03XA02, conivaptan, The metabolism of Conivaptan can be decreased when combined with Methimazole.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Methimazole is combined with Cytarabine.]
[J05AF10, entecavir, The metabolism of Entecavir can be decreased when combined with Methimazole.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Methimazole.]
[M01AH05, etoricoxib, The metabolism of Etoricoxib can be decreased when combined with Methimazole.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Methimazole is combined with Dacarbazine.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Methimazole is combined with Dactinomycin.]
[J04BA02, dapsone, The metabolism of Dapsone can be decreased when combined with Methimazole.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Daunorubicin is combined with Methimazole.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Methimazole.]
[A04AD11, nabilone, The metabolism of Nabilone can be decreased when combined with Methimazole.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be decreased when combined with Methimazole.]
[N07BB05, nalmefene, Methimazole may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[C07AB12, nebivolol, The excretion of Nebivolol can be decreased when combined with Methimazole.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N06AX06, nefazodone, The metabolism of Nefazodone can be decreased when combined with Methimazole.]
[C01DX16, nicorandil, Methimazole may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, The metabolism of Nilutamide can be decreased when combined with Methimazole.]
[N03AG06, tiagabine, The metabolism of Tiagabine can be decreased when combined with Methimazole.]
[G03DB04, nomegestrol, The metabolism of Nomegestrol can be decreased when combined with Methimazole.]
[C01CA23, theodrenaline, Methimazole may decrease the excretion rate of Theodrenaline which could result in a higher serum level.]
[B01AX05, fondaparinux, Methimazole may increase the anticoagulant activities of Fondaparinux.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Methimazole.]
[N06AB10, escitalopram, The metabolism of Escitalopram can be decreased when combined with Methimazole.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be decreased when combined with Methimazole.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N06AA01, desipramine, The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Desipramine.]
[C01AA07, deslanoside, The serum concentration of Deslanoside can be increased when it is combined with Methimazole.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Methimazole.]
[V04CH02, indigo carmine, Methimazole may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C09XA02, aliskiren, The metabolism of Aliskiren can be decreased when combined with Methimazole.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Methimazole.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[S03BA01, dexamethasone, The metabolism of Dexamethasone can be decreased when combined with Methimazole.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be decreased when combined with Methimazole.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Methimazole.]
[L04AB04, adalimumab, The risk or severity of adverse effects can be increased when Adalimumab is combined with Methimazole.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Methimazole.]
[N06BA02, dextroamphetamine, The metabolism of Amphetamine can be decreased when combined with Methimazole.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Methimazole.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Methimazole.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Methimazole.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Methimazole.]
[C04AD01, pentifylline, Methimazole may decrease the excretion rate of Pentifylline which could result in a higher serum level.]
[P03AC04, permethrin, Methimazole may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Methimazole.]
[N06AA08, dibenzepin, The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Dibenzepin.]
[R05DA08, pholcodine, Methimazole may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Methimazole.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[A03AA07, dicyclomine, Methimazole may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Methimazole may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C02DG01, pinacidil, The metabolism of Pinacidil can be decreased when combined with Methimazole.]
[A03AX04, pinaverium, The metabolism of Pinaverium can be decreased when combined with Methimazole.]
[A10BG03, pioglitazone, The metabolism of Pioglitazone can be decreased when combined with Methimazole.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Methimazole.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Methimazole.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Methimazole is combined with Pirarubicin.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, The risk or severity of adverse effects can be increased when Diethylpropion is combined with Methimazole.]
[L02AA01, diethylstilbestrol, The metabolism of Diethylstilbestrol can be decreased when combined with Methimazole.]
[C08CA03, isradipine, The metabolism of Isradipine can be decreased when combined with Methimazole.]
[D07XC04, diflucortolone, The metabolism of Difluocortolone can be decreased when combined with Methimazole.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Methimazole.]
[C01AA05, digoxin, The serum concentration of Digoxin can be increased when it is combined with Methimazole.]
[C02DB01, dihydralazine, The metabolism of Dihydralazine can be decreased when combined with Methimazole.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Methimazole.]
[C04AE04, dihydroergocristine, The serum concentration of Dihydroergocristine can be increased when it is combined with Methimazole.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Methimazole.]
[N02AA03, hydromorphone, The metabolism of Hydromorphone can be decreased when combined with Methimazole.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Methimazole.]
[J05AE08, atazanavir, The metabolism of Atazanavir can be decreased when combined with Methimazole.]
[B01AC21, treprostinil, The metabolism of Treprostinil can be decreased when combined with Methimazole.]
[H03BC01, potassium perchlorate, Methimazole may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be decreased when combined with Methimazole.]
[V03AB09, dimercaprol, Methimazole may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[R03CC08, procaterol, The risk or severity of adverse effects can be increased when Procaterol is combined with Methimazole.]
[M02AX03, dimethyl sulfoxide, Methimazole may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N06BC02, propentofylline, Methimazole may decrease the excretion rate of Propentofylline which could result in a higher serum level.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[R03DA03, proxyphylline, Methimazole may decrease the excretion rate of Proxyphylline which could result in a higher serum level.]
[R06AA02, diphenhydramine, The metabolism of Diphenhydramine can be decreased when combined with Methimazole.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Methimazole.]
[B01AC07, dipyridamole, Methimazole may increase the anticoagulant activities of Dipyridamole.]
[B01AD10, drotrecogin alfa, Methimazole may increase the anticoagulant activities of Drotrecogin alfa.]
[N06AA23, quinupramine, The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Quinupramine.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Methimazole.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Methimazole.]
[N05AL04, remoxipride, The metabolism of Remoxipride can be decreased when combined with Methimazole.]
[S01AX06, resorcinol, The therapeutic efficacy of Methimazole can be decreased when used in combination with Resorcinol.]
[C01BA03, disopyramide, The metabolism of Disopyramide can be decreased when combined with Methimazole.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Natalizumab.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be decreased when combined with Methimazole.]
[J04AB05, rifapentine, The metabolism of Rifapentine can be decreased when combined with Methimazole.]
[N07XX02, riluzole, The metabolism of Riluzole can be decreased when combined with Methimazole.]
[N05AX08, risperidone, The metabolism of Risperidone can be decreased when combined with Methimazole.]
[R06AE09, levocetirizine, The metabolism of Levocetirizine can be decreased when combined with Methimazole.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Methimazole.]
[N01BB09, ropivacaine, The metabolism of Ropivacaine can be decreased when combined with Methimazole.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Methimazole.]
[A04AD12, aprepitant, The metabolism of Aprepitant can be decreased when combined with Methimazole.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Methimazole.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Methimazole.]
[J05AE07, fosamprenavir, The metabolism of Fosamprenavir can be decreased when combined with Methimazole.]
[G04BE08, tadalafil, The serum concentration of Tadalafil can be increased when it is combined with Methimazole.]
[S01BC05, ketorolac, The metabolism of Ketorolac can be decreased when combined with Methimazole.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Methimazole.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be decreased when combined with Methimazole.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[R03AC12, salmeterol, The metabolism of Salmeterol can be decreased when combined with Methimazole.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C01CA07, dobutamine, The risk or severity of adverse effects can be increased when Dobutamine is combined with Methimazole.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Methimazole.]
[C01CA04, dopamine, The risk or severity of adverse effects can be increased when Dopamine is combined with Methimazole.]
[N06AA16, dothiepin, The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Dosulepin.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Methimazole.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Methimazole.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Methimazole.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be decreased when combined with Methimazole.]
[A08AA10, sibutramine, The metabolism of Sibutramine can be decreased when combined with Methimazole.]
[C10AA01, simvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Methimazole is combined with Simvastatin.]
[A12CA02, sodium sulfate, Methimazole may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[G03DB01, dydrogesterone, The metabolism of Dydrogesterone can be decreased when combined with Methimazole.]
[R03DA01, dyphylline, Methimazole may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[V04CX07, edrophonium, Methimazole may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, The excretion of Talinolol can be decreased when combined with Methimazole.]
[H01AA01, corticotropin, The metabolism of Corticotropin can be decreased when combined with Methimazole.]
[J01MA05, temafloxacin, The metabolism of Temafloxacin can be decreased when combined with Methimazole.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Methimazole is combined with Temozolomide.]
[M01AC02, tenoxicam, The metabolism of Tenoxicam can be decreased when combined with Methimazole.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Methimazole.]
[G04BD05, terodiline, The metabolism of Terodiline can be decreased when combined with Methimazole.]
[C07AA16, tertatolol, The excretion of Tertatolol can be decreased when combined with Methimazole.]
[S01GA02, tetrahydrozoline, The risk or severity of adverse effects can be increased when Tetryzoline is combined with Methimazole.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Methimazole.]
[M01AG02, tolfenamic acid, The metabolism of Tolfenamic acid can be decreased when combined with Methimazole.]
[N06AG03, toloxatone, Methimazole may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Methimazole.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L02BA02, toremifene, The metabolism of Toremifene can be decreased when combined with Methimazole.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[R01AA09, tramazoline, The risk or severity of adverse effects can be increased when Tramazoline is combined with Methimazole.]
[N05CC01, chloral hydrate, Methimazole may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[B01AC18, triflusal, Methimazole may increase the anticoagulant activities of Triflusal.]
[H02CA01, trilostane, The metabolism of Trilostane can be decreased when combined with Methimazole.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Methimazole is combined with Trofosfamide.]
[C05CA04, troxerutin, Methimazole may increase the anticoagulant activities of Troxerutin.]
[N01AB04, enflurane, The metabolism of Enflurane can be decreased when combined with Methimazole.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Methimazole.]
[S01FB02, ephedrine, The risk or severity of adverse effects can be increased when Ephedrine is combined with Methimazole.]
[S01GX10, epinastine, The metabolism of Epinastine can be decreased when combined with Methimazole.]
[N06AX16, venlafaxine, The metabolism of Venlafaxine can be decreased when combined with Methimazole.]
[C08CA12, mepirodipine, The metabolism of Barnidipine can be decreased when combined with Methimazole.]
[S01EA01, epinephrine, The risk or severity of adverse effects can be increased when Epinephrine is combined with Methimazole.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Methimazole.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Methimazole.]
[M01AB04, zomepirac, The metabolism of Zomepirac can be decreased when combined with Methimazole.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be decreased when combined with Methimazole.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Methimazole.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Methimazole.]
[N05AX11, zotepine, The metabolism of Zotepine can be decreased when combined with Methimazole.]
[B01AD03, anistreplase, Methimazole may increase the anticoagulant activities of Anistreplase.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Methimazole is combined with Carboplatin.]
[C02AC02, guanfacine, The metabolism of Guanfacine can be decreased when combined with Methimazole.]
[B01AC11, iloprost, The risk or severity of bleeding can be increased when Iloprost is combined with Methimazole.]
[G02AB03, ergonovine, The serum concentration of Ergometrine can be increased when it is combined with Methimazole.]
[C04AE01, ergoloid mesylates, USP, The serum concentration of Ergoloid mesylate can be increased when it is combined with Methimazole.]
[N02CA02, ergotamine, The metabolism of Ergotamine can be decreased when combined with Methimazole.]
[N03AG01, valproic acid, The metabolism of Valproic acid can be decreased when combined with Methimazole.]
[L03AX05, pidotimod, Methimazole may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The metabolism of Erythromycin can be decreased when combined with Methimazole.]
[N05CD04, estazolam, The metabolism of Estazolam can be decreased when combined with Methimazole.]
[A02BC02, pantoprazole, The metabolism of Pantoprazole can be decreased when combined with Methimazole.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be decreased when combined with Methimazole.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Methimazole.]
[L01XX11, estramustine, The metabolism of Estramustine can be decreased when combined with Methimazole.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Methimazole.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Methimazole is combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Methimazole.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C01CA15, gepefrine, The risk or severity of adverse effects can be increased when Gepefrine is combined with Methimazole.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Methimazole.]
[J04AD03, ethionamide, The therapeutic efficacy of Methimazole can be decreased when used in combination with Ethionamide.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N03AD01, ethosuximide, The metabolism of Ethosuximide can be decreased when combined with Methimazole.]
[M01AC06, meloxicam, The metabolism of Meloxicam can be decreased when combined with Methimazole.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Methimazole.]
[C01CA01, etilefrine, The risk or severity of adverse effects can be increased when Etilefrine is combined with Methimazole.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Methimazole.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Methimazole.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Methimazole.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Methimazole.]
[R06AX12, terfenadine, The metabolism of Terfenadine can be decreased when combined with Methimazole.]
[P01AX07, trimetrexate, Methimazole may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, The serum concentration of Bupropion can be increased when it is combined with Methimazole.]
[N06AB08, fluvoxamine, The metabolism of Fluvoxamine can be decreased when combined with Methimazole.]
[C01BB03, tocainide, The metabolism of Tocainide can be decreased when combined with Methimazole.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Methimazole.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Methimazole.]
[M01CB01, gold sodium thiomalate, Methimazole may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[A05AA01, chenodeoxycholic acid, The metabolism of Chenodeoxycholic acid can be decreased when combined with Methimazole.]
[B05AA05, dextran, Methimazole may increase the anticoagulant activities of Dextran.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Methimazole.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Methimazole.]
[C08CA02, felodipine, The metabolism of Felodipine can be decreased when combined with Methimazole.]
[C08EA01, fendiline, The metabolism of Fendiline can be decreased when combined with Methimazole.]
[N03AX26, fenfluramine, The metabolism of Fenfluramine can be decreased when combined with Methimazole.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[R03CC04, fenoterol, The risk or severity of adverse effects can be increased when Fenoterol is combined with Methimazole.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Methimazole.]
[R03CC02, albuterol, Methimazole may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[B01AD05, plasmin, Methimazole may increase the anticoagulant activities of Fibrinolysin.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Methimazole.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Methimazole.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Methimazole.]
[G04BD02, flavoxate, Methimazole may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Methimazole.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Methimazole is combined with Flucytosine.]
[H02AA02, fludrocortisone, The metabolism of Fludrocortisone can be decreased when combined with Methimazole.]
[V03AB25, flumazenil, Methimazole may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[D07XB01, flumethasone, The metabolism of Flumethasone can be decreased when combined with Methimazole.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Methimazole.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Methimazole.]
[D07AC08, fluocinonide, The metabolism of Fluocinonide can be decreased when combined with Methimazole.]
[N06AA14, melitracen, The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Melitracen.]
[H02AB03, fluocortolone, The metabolism of Fluocortolone can be decreased when combined with Methimazole.]
[V03AZ01, ethanol, The metabolism of Ethanol can be decreased when combined with Methimazole.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Methimazole.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Methimazole.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Methimazole.]
[N06AB03, fluoxetine, The metabolism of Fluoxetine can be decreased when combined with Methimazole.]
[N05AF01, flupenthixol, The risk or severity of myelosuppression can be increased when Flupentixol is combined with Methimazole.]
[N05CD01, flurazepam, The metabolism of Flurazepam can be decreased when combined with Methimazole.]
[S01BC04, flurbiprofen, The metabolism of Flurbiprofen can be decreased when combined with Methimazole.]
[N05AG01, fluspirilene, The metabolism of Fluspirilene can be decreased when combined with Methimazole.]
[L02BB01, flutamide, The metabolism of Flutamide can be decreased when combined with Methimazole.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[S02AA17, fosfomycin, Methimazole may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Methimazole.]
[J05AE10, darunavir, The metabolism of Darunavir can be decreased when combined with Methimazole.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, The serum concentration of Eszopiclone can be increased when it is combined with Methimazole.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Methimazole.]
[C08DA02, gallopamil, The metabolism of Gallopamil can be decreased when combined with Methimazole.]
[S01AD09, ganciclovir, Methimazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AB04, gemfibrozil, The metabolism of Gemfibrozil can be decreased when combined with Methimazole.]
[J01XA03, telavancin, Methimazole may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Methimazole.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Methimazole.]
[C01CA21, cafedrine, Methimazole may decrease the excretion rate of Cafedrine which could result in a higher serum level.]
[J05AG04, etravirine, The metabolism of Etravirine can be decreased when combined with Methimazole.]
[N03AD03, methsuximide, The metabolism of Methsuximide can be decreased when combined with Methimazole.]
[G03XA02, gestrinone, The metabolism of Gestrinone can be decreased when combined with Methimazole.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be decreased when combined with Methimazole.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Methimazole.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Methimazole.]
[A10BB09, gliclazide, The therapeutic efficacy of Gliclazide can be decreased when used in combination with Methimazole.]
[A10BB07, glipizide, The therapeutic efficacy of Glipizide can be decreased when used in combination with Methimazole.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Methimazole.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Methimazole.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Methimazole.]
[C07AB09, esmolol, The excretion of Esmolol can be decreased when combined with Methimazole.]
[M01CB04, aurothioglucose, Methimazole may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Methimazole may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, Methimazole may decrease the anticoagulant activities of Fluindione.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[S01EX01, guanethidine, Methimazole may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Methimazole.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Methimazole.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Methimazole.]
[N05AH04, quetiapine, The serum concentration of Quetiapine can be increased when it is combined with Methimazole.]
[N06BX13, idebenone, Methimazole may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Methimazole.]
[L01CE02, irinotecan, The serum concentration of SN-38, an active metabolite of Irinotecan, can be increased when used in combination with Methimazole.]
[M04AA01, allopurinol, The risk or severity of adverse effects can be increased when Allopurinol is combined with Methimazole.]
[C09CA01, losartan, The metabolism of Losartan can be decreased when combined with Methimazole.]
[S01XA14, heparin, Methimazole may increase the anticoagulant activities of Heparin.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Methimazole.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Methimazole.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Methimazole.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Methimazole.]
[C08CA10, nilvadipine, The metabolism of Nilvadipine can be decreased when combined with Methimazole.]
[M02AA26, nimesulide, The metabolism of Nimesulide can be decreased when combined with Methimazole.]
[C09AA04, perindopril, Methimazole may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C02DB02, hydralazine, Methimazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be decreased when combined with Methimazole.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be decreased when combined with Methimazole.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Methimazole.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Methimazole may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[G04BD06, propiverine, The metabolism of Propiverine can be decreased when combined with Methimazole.]
[P01BA02, hydroxychloroquine, The metabolism of Hydroxychloroquine can be decreased when combined with Methimazole.]
[B05AA07, hetastarch, Methimazole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[G03DA03, 17-alpha-hydroxyprogesterone, The metabolism of Hydroxyprogesterone can be decreased when combined with Methimazole.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Methimazole is combined with Hydroxyurea.]
[N05BB01, hydroxyzine, The metabolism of Hydroxyzine can be decreased when combined with Methimazole.]
[J04AB04, rifabutin, The metabolism of Rifabutin can be decreased when combined with Methimazole.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Methimazole.]
[B05XA08, sodium acetate, Methimazole may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[B05CB02, sodium citrate, Methimazole may increase the anticoagulant activities of Sodium citrate.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Methimazole is combined with Idarubicin.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Methimazole.]
[N01AH03, sufentanil, The metabolism of Sufentanil can be decreased when combined with Methimazole.]
[N06AA02, imipramine, The metabolism of Imipramine can be decreased when combined with Methimazole.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Methimazole.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Methimazole is combined with Tixocortol.]
[M03BX02, tizanidine, The metabolism of Tizanidine can be decreased when combined with Methimazole.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Methimazole is combined with Topotecan.]
[C03BA11, indapamide, The metabolism of Indapamide can be decreased when combined with Methimazole.]
[S01BC01, indomethacin, The risk or severity of adverse effects can be increased when Indomethacin is combined with Methimazole.]
[A11HA07, inositol, Methimazole may decrease the excretion rate of Inositol which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Methimazole.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Methimazole.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be decreased when combined with Methimazole.]
[S01XA28, varenicline, Methimazole may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Eculizumab.]
[A10BH01, sitagliptin, The metabolism of Sitagliptin can be decreased when combined with Methimazole.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Methimazole.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Methimazole.]
[C10AA06, cerivastatin, The metabolism of Cerivastatin can be decreased when combined with Methimazole.]
[L01XX35, anagrelide, The metabolism of Anagrelide can be decreased when combined with Methimazole.]
[C07AA01, alprenolol, The excretion of Alprenolol can be decreased when combined with Methimazole.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Methimazole.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Methimazole.]
[N06AA13, iprindole, The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Iprindole.]
[J05AB13, penciclovir, The metabolism of Penciclovir can be decreased when combined with Methimazole.]
[P01AX06, atovaquone, The metabolism of Atovaquone can be decreased when combined with Methimazole.]
[N01AB06, isoflurane, The metabolism of Isoflurane can be decreased when combined with Methimazole.]
[J04AC01, isoniazid, Methimazole may decrease the excretion rate of Isoniazid which could result in a higher serum level.]
[J05AX05, inosine pranobex, Methimazole may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[R03CB01, isoproterenol, The risk or severity of adverse effects can be increased when Isoprenaline is combined with Methimazole.]
[C01DA14, isosorbide mononitrate, Methimazole may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[D10BA01, isotretinoin, The metabolism of Isotretinoin can be decreased when combined with Methimazole.]
[C04AA01, isoxsuprine, The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Methimazole.]
[P02CF01, ivermectin, The metabolism of Ivermectin can be decreased when combined with Methimazole.]
[B01AE06, bivalirudin, Methimazole may increase the anticoagulant activities of Bivalirudin.]
[N06AX18, reboxetine, The metabolism of Reboxetine can be decreased when combined with Methimazole.]
[S01AA24, kanamycin, Methimazole may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[L04AC07, tocilizumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Methimazole.]
[C02KD01, ketanserin, The risk or severity of bleeding can be increased when Ketanserin is combined with Methimazole.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Methimazole.]
[J02AB02, ketoconazole, The metabolism of Ketoconazole can be decreased when combined with Methimazole.]
[H02CA04, levoketoconazole, The metabolism of Levoketoconazole can be decreased when combined with Methimazole.]
[N05AH03, olanzapine, The metabolism of Olanzapine can be decreased when combined with Methimazole.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L04AA24, abatacept, The risk or severity of adverse effects can be increased when Methimazole is combined with Abatacept.]
[N04BC09, rotigotine, The metabolism of Rotigotine can be decreased when combined with Methimazole.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C07AG01, labetalol, The excretion of Labetalol can be decreased when combined with Methimazole.]
[N04BB01, amantadine, Methimazole may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[J05AX09, maraviroc, The metabolism of Maraviroc can be decreased when combined with Methimazole.]
[A06AX03, lubiprostone, Methimazole may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Methimazole.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[R05CB06, ambroxol, The metabolism of Ambroxol can be decreased when combined with Methimazole.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Methimazole.]
[G03AD01, levonorgestrel, The metabolism of Levonorgestrel can be decreased when combined with Methimazole.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be decreased when combined with Methimazole.]
[C08EX01, lidoflazine, The metabolism of Lidoflazine can be decreased when combined with Methimazole.]
[S01AA21, amikacin, Methimazole may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Methimazole.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, The serum concentration of Lisuride can be increased when it is combined with Methimazole.]
[N06AA07, lofepramine, The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Lofepramine.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Methimazole is combined with Lomustine.]
[A07DA03, loperamide, The metabolism of Loperamide can be decreased when combined with Methimazole.]
[N05BA06, lorazepam, The metabolism of Lorazepam can be decreased when combined with Methimazole.]
[C10AA02, lovastatin, The serum concentration of Lovastatin can be increased when it is combined with Methimazole.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Methimazole.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Methimazole.]
[B05XA11, magnesium chloride, Methimazole may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Methimazole may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Methimazole is combined with Pralatrexate.]
[L01EA03, nilotinib, The metabolism of Nilotinib can be decreased when combined with Methimazole.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Methimazole.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Methimazole is combined with Mechlorethamine.]
[R06AE05, meclizine, The metabolism of Meclizine can be decreased when combined with Methimazole.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C01AA08, medigoxin, The serum concentration of Metildigoxin can be increased when it is combined with Methimazole.]
[G03DB03, medrogestone, The metabolism of Medrogestone can be decreased when combined with Methimazole.]
[P01BC02, mefloquine, The metabolism of Mefloquine can be decreased when combined with Methimazole.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, Methimazole may increase the anticoagulant activities of Nadroparin.]
[B01AB05, enoxaparin, Methimazole may increase the anticoagulant activities of Enoxaparin.]
[B01AB04, dalteparin, Methimazole may increase the anticoagulant activities of Dalteparin.]
[N05CH01, melatonin, The metabolism of Melatonin can be decreased when combined with Methimazole.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Methimazole is combined with Melphalan.]
[N06DX01, memantine, Methimazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, The metabolism of Meperidine can be decreased when combined with Methimazole.]
[C01CA11, mephentermine, The risk or severity of adverse effects can be increased when Mephentermine is combined with Methimazole.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Methimazole.]
[N03AA01, mephobarbital, The metabolism of Methylphenobarbital can be decreased when combined with Methimazole.]
[N01BB03, mepivacaine, Methimazole may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G04BX16, tiopronin, Methimazole may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AC03, mesoridazine, The metabolism of Mesoridazine can be decreased when combined with Methimazole.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Methimazole.]
[C01CA09, metaraminol, The risk or severity of adverse effects can be increased when Metaraminol is combined with Methimazole.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be decreased when combined with Methimazole.]
[N07BC02, methadone, The metabolism of Methadone can be decreased when combined with Methimazole.]
[N06BA03, methamphetamine, The metabolism of Metamfetamine can be decreased when combined with Methimazole.]
[N05CM01, methaqualone, The metabolism of Methaqualone can be decreased when combined with Methimazole.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[G02CB05, metergoline, The serum concentration of Metergoline can be increased when it is combined with Methimazole.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Methimazole is combined with Antilymphocyte immunoglobulin (horse).]
[C01DA05, pentaerythritol tetranitrate, Methimazole may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The metabolism of Fluticasone furoate can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Pemetrexed is combined with Methimazole.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Methimazole.]
[N05AA02, methotrimeprazine, The metabolism of Methotrimeprazine can be decreased when combined with Methimazole.]
[C01CA10, methoxamine, The risk or severity of adverse effects can be increased when Methoxamine is combined with Methimazole.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Methimazole.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Methimazole may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[V04CG05, methylene blue, The metabolism of Methylene blue can be decreased when combined with Methimazole.]
[G02AB01, methylergonovine, The serum concentration of Methylergometrine can be increased when it is combined with Methimazole.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Methimazole.]
[H02AB04, methylprednisolone, The metabolism of Methylprednisolone can be decreased when combined with Methimazole.]
[G03EK01, methyltestosterone, The metabolism of Methyltestosterone can be decreased when combined with Methimazole.]
[N02CA04, methysergide, The serum concentration of Methysergide can be increased when it is combined with Methimazole.]
[A03FA01, metoclopramide, The metabolism of Metoclopramide can be decreased when combined with Methimazole.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, The excretion of Metoprolol can be decreased when combined with Methimazole.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be decreased when combined with Methimazole.]
[V04CD01, metyrapone, Methimazole may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Methimazole.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Methimazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Methimazole.]
[B01AB07, parnaparin, Methimazole may increase the anticoagulant activities of Parnaparin.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Methimazole.]
[C01CA17, midodrine, The risk or severity of adverse effects can be increased when Midodrine is combined with Methimazole.]
[G03XB01, mifepristone, The metabolism of Mifepristone can be decreased when combined with Methimazole.]
[B01AB10, tinzaparin, Methimazole may increase the anticoagulant activities of Tinzaparin.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C09CA03, valsartan, The metabolism of Valsartan can be decreased when combined with Methimazole.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Methimazole is combined with Mitoxantrone.]
[N06BA12, lisdexamfetamine, The metabolism of Lisdexamfetamine can be decreased when combined with Methimazole.]
[L03AC01, aldesleukin, The therapeutic efficacy of Methimazole can be decreased when used in combination with Aldesleukin.]
[C01BD01, amiodarone, The therapeutic efficacy of Methimazole can be decreased when used in combination with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Methimazole.]
[N02AA01, morphine, The metabolism of Morphine can be decreased when combined with Methimazole.]
[A04AA05, palonosetron, The metabolism of Palonosetron can be decreased when combined with Methimazole.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The risk or severity of adverse effects can be increased when Methimazole is combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Methimazole.]
[G04BA01, ammonium chloride, Methimazole may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Ofatumumab.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Methimazole.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Methimazole is combined with Mycophenolic acid.]
[G04CA04, silodosin, The metabolism of Silodosin can be decreased when combined with Methimazole.]
[N06AA17, amoxapine, The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Amoxapine.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Methimazole.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Methimazole.]
[C07AA12, nadolol, The excretion of Nadolol can be decreased when combined with Methimazole.]
[J01CA04, amoxicillin, Methimazole may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Methimazole is combined with Ropinirole.]
[V03AB15, naloxone, Methimazole may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[L04AC03, anakinra, The risk or severity of adverse effects can be increased when Anakinra is combined with Methimazole.]
[S01GA01, naphazoline, The risk or severity of adverse effects can be increased when Naphazoline is combined with Methimazole.]
[N06BA01, amphetamine, The metabolism of Amphetamine can be decreased when combined with Methimazole.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Methimazole.]
[A10BG01, troglitazone, The metabolism of Troglitazone can be decreased when combined with Methimazole.]
[N06AX21, duloxetine, The metabolism of Duloxetine can be decreased when combined with Methimazole.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Methimazole.]
[L02BG04, letrozole, The metabolism of Letrozole can be decreased when combined with Methimazole.]
[S03AA01, neomycin, Methimazole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A10BX02, repaglinide, The metabolism of Repaglinide can be decreased when combined with Methimazole.]
[B01AC17, tirofiban, The risk or severity of bleeding can be increased when Tirofiban is combined with Methimazole.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Methimazole.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L03AX16, plerixafor, Methimazole may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Methimazole may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Desvenlafaxine can be decreased when combined with Methimazole.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[H05BX02, paricalcitol, The metabolism of Paricalcitol can be decreased when combined with Methimazole.]
[C01CE01, inamrinone, Methimazole may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Methimazole.]
[C08CA04, nicardipine, The metabolism of Nicardipine can be decreased when combined with Methimazole.]
[C04AE02, nicergoline, The serum concentration of Nicergoline can be increased when it is combined with Methimazole.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Methimazole.]
[N07BA01, nicotine, The metabolism of Nicotine can be decreased when combined with Methimazole.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Methimazole.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C08CA06, nimodipine, The metabolism of Nimodipine can be decreased when combined with Methimazole.]
[C08CA07, nisoldipine, The metabolism of Nisoldipine can be decreased when combined with Methimazole.]
[N05CD02, nitrazepam, The metabolism of Nitrazepam can be decreased when combined with Methimazole.]
[C08CA08, nitrendipine, The metabolism of Nitrendipine can be decreased when combined with Methimazole.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be decreased when combined with Methimazole.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C01CA03, norepinephrine, The risk or severity of adverse effects can be increased when Norepinephrine is combined with Methimazole.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Methimazole.]
[C02KX01, bosentan, The metabolism of Bosentan can be decreased when combined with Methimazole.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Methimazole.]
[B01AC16, eptifibatide, The risk or severity of bleeding can be increased when Eptifibatide is combined with Methimazole.]
[G02CA02, nylidrin, The metabolism of Nylidrin can be decreased when combined with Methimazole.]
[B01AB08, reviparin, Methimazole may increase the anticoagulant activities of Reviparin.]
[L04AC04, rilonacept, The risk or severity of adverse effects can be increased when Methimazole is combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Omeprazole can be decreased when combined with Methimazole.]
[N06AA05, opipramol, The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Opipramol.]
[N02AA02, opium, The metabolism of Opium can be decreased when combined with Methimazole.]
[R03CB03, metaproterenol, The risk or severity of adverse effects can be increased when Orciprenaline is combined with Methimazole.]
[B01AD07, reteplase, Methimazole may increase the anticoagulant activities of Reteplase.]
[B01AD09, ancrod, Methimazole may increase the anticoagulant activities of Ancrod.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Methimazole.]
[C01AC01, ouabain, The serum concentration of Ouabain can be increased when it is combined with Methimazole.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N05BA04, oxazepam, Methimazole may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[C07AA02, oxprenolol, The excretion of Oxprenolol can be decreased when combined with Methimazole.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be decreased when combined with Methimazole.]
[S01GA04, oxymetazoline, The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Methimazole.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be decreased when combined with Methimazole.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J04AA01, aminosalicylic acid, The therapeutic efficacy of Methimazole can be decreased when used in combination with Aminosalicylic acid.]
[N05AH05, asenapine, The metabolism of Asenapine can be decreased when combined with Methimazole.]
[B01AB09, danaparoid, Methimazole may increase the anticoagulant activities of Danaparoid.]
[J04AB30, capreomycin, Methimazole may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G03DB06, chlormadinone, The metabolism of Chlormadinone can be decreased when combined with Methimazole.]
[H02AB05, paramethasone, The metabolism of Paramethasone can be decreased when combined with Methimazole.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Methimazole.]
[C07AA23, penbutolol, The excretion of Penbutolol can be decreased when combined with Methimazole.]
[N05AG03, penfluridol, The metabolism of Penfluridol can be decreased when combined with Methimazole.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Methimazole is combined with Penicillamine.]
[J01CE09, penicillin G procaine, Methimazole may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Methimazole.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Methimazole.]
[N05CA01, pentobarbital, The metabolism of Pentobarbital can be decreased when combined with Methimazole.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Methimazole.]
[C04AD03, pentoxifylline, Methimazole may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N04BC02, pergolide, The serum concentration of Pergolide can be increased when it is combined with Methimazole.]
[C08EX02, perhexiline, The metabolism of Perhexiline can be decreased when combined with Methimazole.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be decreased when combined with Methimazole.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Methimazole.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Methimazole.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N06AF03, phenelzine, Methimazole may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Methimazole.]
[B01AA02, phenindione, Methimazole may decrease the anticoagulant activities of Phenindione.]
[N03AA02, phenobarbital, The metabolism of Phenobarbital can be decreased when combined with Methimazole.]
[B01AA04, phenprocoumon, Methimazole may decrease the anticoagulant activities of Phenprocoumon.]
[A08AA01, phentermine, The metabolism of Phentermine can be decreased when combined with Methimazole.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[M02AA01, phenylbutazone, The metabolism of Phenylbutazone can be decreased when combined with Methimazole.]
[S01GA05, phenylephrine, The risk or severity of adverse effects can be increased when Phenylephrine is combined with Methimazole.]
[A02BC06, dexlansoprazole, The metabolism of Dexlansoprazole can be decreased when combined with Methimazole.]
[R01BA01, phenylpropanolamine, The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Methimazole.]
[N03AB02, phenytoin, The metabolism of Phenytoin can be decreased when combined with Methimazole.]
[L04AB06, golimumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Golimumab.]
[S01AE05, levofloxacin, Methimazole may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Methimazole.]
[B02BA01, vitamin K1, Methimazole may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[C08CX01, mibefradil, The metabolism of Mibefradil can be decreased when combined with Methimazole.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Methimazole.]
[C07AA03, pindolol, The excretion of Pindolol can be decreased when combined with Methimazole.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Methimazole.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J05AE01, saquinavir, The metabolism of Saquinavir can be decreased when combined with Methimazole.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Methimazole.]
[N05AC04, pipothiazine, The metabolism of Pipotiazine can be decreased when combined with Methimazole.]
[N06BX03, piracetam, Methimazole may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[S01BC06, piroxicam, The metabolism of Piroxicam can be decreased when combined with Methimazole.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J01MA11, grepafloxacin, The metabolism of Grepafloxacin can be decreased when combined with Methimazole.]
[J05AG02, delavirdine, The metabolism of Delavirdine can be decreased when combined with Methimazole.]
[C09CA04, irbesartan, The metabolism of Irbesartan can be decreased when combined with Methimazole.]
[B01AC13, abciximab, Methimazole may increase the anticoagulant activities of Abciximab.]
[S01XA13, alteplase, Methimazole may increase the anticoagulant activities of Alteplase.]
[A10BG02, rosiglitazone, The metabolism of Rosiglitazone can be decreased when combined with Methimazole.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Methimazole.]
[L04AC08, canakinumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Canakinumab.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The metabolism of Ritonavir can be decreased when combined with Methimazole.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be decreased when combined with Methimazole.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Methimazole.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Methimazole.]
[C07AB01, practolol, The excretion of Practolol can be decreased when combined with Methimazole.]
[N05BA11, prazepam, The metabolism of Prazepam can be decreased when combined with Methimazole.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Methimazole.]
[S03BA02, prednisolone, Methimazole may increase the excretion rate of Prednisolone which could result in a lower serum level and potentially a reduction in efficacy.]
[H02AB07, prednisone, Methimazole may increase the excretion rate of Prednisone which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DX02, prenylamine, The metabolism of Prenylamine can be decreased when combined with Methimazole.]
[P01BA03, primaquine, The metabolism of Primaquine can be decreased when combined with Methimazole.]
[N03AA03, primidone, The metabolism of Primidone can be decreased when combined with Methimazole.]
[M04AB01, probenecid, Methimazole may decrease the excretion rate of Probenecid which could result in a higher serum level.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Methimazole.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Methimazole is combined with Procarbazine.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Methimazole.]
[N05AB04, prochlorperazine, The metabolism of Prochlorperazine can be decreased when combined with Methimazole.]
[G03DA04, progesterone, The metabolism of Progesterone can be decreased when combined with Methimazole.]
[N05AA03, promazine, The metabolism of Promazine can be decreased when combined with Methimazole.]
[G03DB07, promegestone, The metabolism of Promegestone can be decreased when combined with Methimazole.]
[R06AD02, promethazine, The metabolism of Promethazine can be decreased when combined with Methimazole.]
[C01BC03, propafenone, The excretion of Propafenone can be decreased when combined with Methimazole.]
[A03AB05, propantheline, Methimazole may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Methimazole.]
[N01AX10, propofol, The metabolism of Propofol can be decreased when combined with Methimazole.]
[N02AC04, propoxyphene, The metabolism of Dextropropoxyphene can be decreased when combined with Methimazole.]
[C07AA05, propranolol, The excretion of Propranolol can be decreased when combined with Methimazole.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Methimazole.]
[C01AB01, proscillaridin, The serum concentration of Proscillaridin can be increased when it is combined with Methimazole.]
[N02CC04, rizatriptan, Methimazole may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, Methimazole may increase the anticoagulant activities of Epoprostenol.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Methimazole.]
[N06AA11, protriptyline, The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Protriptyline.]
[R01BA02, pseudoephedrine, The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Methimazole.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Methimazole.]
[N07XX07, dalfampridine, Methimazole may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Methimazole may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Methimazole.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Methimazole.]
[C01BA01, quinidine, The metabolism of Quinidine can be decreased when combined with Methimazole.]
[P01BC01, quinine, The metabolism of Quinine can be decreased when combined with Methimazole.]
[A02BA02, ranitidine, The metabolism of Ranitidine can be decreased when combined with Methimazole.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[J05AP01, ribavirin, Methimazole may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[G02CA01, ritodrine, The risk or severity of adverse effects can be increased when Ritodrine is combined with Methimazole.]
[J01FA06, roxithromycin, The metabolism of Roxithromycin can be decreased when combined with Methimazole.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[A07EC01, sulfasalazine, The risk or severity of adverse effects can be increased when Methimazole is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The metabolism of Salicylic acid can be decreased when combined with Methimazole.]
[S01FA02, scopolamine, The metabolism of Scopolamine can be decreased when combined with Methimazole.]
[N05CA06, secobarbital, Secobarbital may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Methimazole.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Methimazole is combined with Obinutuzumab.]
[J01GB08, sisomicin, Methimazole may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Methimazole may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V10XA01, sodium iodide I131, The therapeutic efficacy of Iodide I-131 can be decreased when used in combination with Methimazole.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Methimazole.]
[V04CC01, sorbitol, Methimazole may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The excretion of Sotalol can be decreased when combined with Methimazole.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Methimazole.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Methimazole.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
